Importance of Cell Line Authentication Tests for Cancer Research in India Cell lines play a critical role in cancer research, the development of medicines and drugs, as well as genetic studies. In India, it is essential to obtain Cell Line Authentication Tests to ensure the quality and integrity of research. Several specialized laboratories and biotechnology companies in India offer cell line authentication services. DNA Forensics Laboratory Pvt. Ltd. is a leading provider of accurate and reliable Cell Line Authentication tests in India. Our comprehensive services cover human cell line authentication using STR profiling techniques. We have partnered with renowned research institutes, pharmaceutical firms, and biotechnology companies, solidifying our reputation as a trusted provider. To learn more or to book a Cell Line Test in India, contact our customer service representatives at +91 8010177771 or reach out to us on WhatsApp at +91 9213177771. #CellLineAuthenticationTestInIndia #CellLineAuthentication

DNA Forensics Laboratory for Cell Line Authentication Test in India Cell line authentication is a crucial process for ensuring the reliability of scientific research. This is because it confirms the identity of the cell line being used and prevents the possibility of cross-contamination or misidentification. Authentication is critical in biotechnology and medical research, where cell lines are used to develop new therapies and treatments. However, the authenticity of cell lines can be compromised due to errors in labeling, improper storage, or accidental contamination. This is where the DNA Forensics Laboratory comes in to help. As a leading provider of Cell Line Authentication Tests in India, they use advanced DNA profiling techniques to identify and authenticate the cell lines used in research accurately. We are a NABL-accredited laboratory that provides accredited DNA testing services at reasonable prices. To learn more or to book a Cell Line Test in India, talk to our customer service representatives on the numbers Call: +91 8010177771 or WhatsApp: + 91 9213177771. #CellLineAuthenticationTestInIndia #CellLineAuthentication

The Role of Fetal Bovine Serum Market in Biotechnology The Fetal Bovine Serum Market was estimated at US$ 874.1 million in 2021 and is expected to grow at a CAGR of 5.18% during 2022-2028 to reach US$ ~1190 million in 2028. Read more- https://www.stratviewresearch.com/3158/fetal-bovine-serum-market.html

Manufacturing Execution System Market Global Industry Analysis by Growth, Trends & Emerging Opportunities No matter the magnitude of a manufacturing procedure, a manufacturing execution system can contribute to total efficiency and effectiveness by creating a manufacturing procedure data-driven. Structured sectors like food and beverage, pharmaceuticals, aerospace and aeronautics, medical devices, defense, and biotechnology mainly benefit because regulated businesses should adhere to severe guidelines to guarantee traceability compliance. They should ensure that the right procedures are in place for building compliant items, that such procedures are recognized, and that the resulting products can be effortlessly recalled if essential. The manufacturing execution system market is witnessing growth and is projected to reach USD 25.8 billion by 2030. Benefits of Manufacturing Execution Systems MES monitors an enormous size of information, creating real-time insights that can fuel production effectiveness and save money. Other advantages of a manufacturing execution system include: Improved Quality Control: As quality control data is conveyed in real-time, businesses with a manufacturing execution system can directly stop manufacturing as soon as problems are recognized. This decreases overages, waste, scrap, and re-work. For Getting More Insights of This Report:- https://www.psmarketresearch.com/market-analysis/manufacturing-execution-system-market Augmented Uptime: A manufacturing execution system generates accurate construction schedules by balancing material, personnel, and equipment resources. It comprises preparation and maintenance to make the most of item flow and asset usage – growing uptime and advancing overall equipment effectiveness (OEE). Reduced Inventory: In order to ensure your purchasing, shipping, and scheduling departments know precisely what material is available at all times, a manufacturing execution system shall update the inventory of newly produced, scrap, or nonconforming materials with up-to-date information. This decreases just-in-case inventory and work-in-progress (WIP) inventory – saving money on manufacturing, transportation, storage, and inventory monitoring. Paperless Shop Floor: Removing bookkeeping means there is a very low chance of human blunder. It also means that the information noted from the shop floor is directly obtainable to decision-makers across all combined systems, to notify real-time decision-making. The requirement for manufacturing implementation solutions will enlarge during the forecast period because of the numerous COVID-19 processes and commendations that have been stated for simpler operations.

Microbial Identification Market Share, Size, Future Demand, and Emerging Trends The food and beverage industry is increasingly adopting microbial identification products, due to the growing concerns regarding food safety. Food and beverage companies use these products to detect unwanted microorganisms and prevent the contamination of food items. Regular detection of microorganisms is required in food products, as any alteration in storage temperature, pH value, water activity, relative humidity, and gas composition of storage units leads to the growth of microbes in these items. The growth of microbes results in food spoilage and food poisoning, which can be avoided by the use of microbial identification products. The food and beverage industry is increasingly adopting microbial identification products, due to the growing concerns regarding food safety. Food and beverage companies use these products to detect unwanted microorganisms and prevent the contamination of food items. Regular detection of microorganisms is required in food products, as any alteration in storage temperature, pH value, water activity, relative humidity, and gas composition of storage units leads to the growth of microbes in these items. The growth of microbes results in food spoilage and food poisoning, which can be avoided by the use of microbial identification products. Browse detailed - https://www.psmarketresearch.com/market-analysis/microbial-identification-market Currently, the market players and end users are shifting their focus from conventional phenotypic method to genotypic identification method, as the latter is more reliable and accurate because it is based on nucleic acid analysis. The genotypic method is directed toward deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) molecules for bacterial identification and classification. Species-specific typing and strain-specific typing are the two types of the genotypic microbial identification method being deployed by several end-users, worldwide. According to P&S Intelligence, the Asia-Pacific (APAC) microbial identification market will advance at the highest rate in the coming years, globally, due to the surging use of microbial identification products in Japan, India, and China. These products are widely adopted in pharmaceutical and biotechnology companies, blood banks, and research institutes of the region. Among APAC nations, Japan is expected to consume the highest volume of such products in the coming years. Thus, the surging concerns regarding food safety and the increasing incidence of infectious diseases will augment the usage of microbial identification products in the coming years.

Digital Pathology Market to Grow at a Robust Pace During 2022-2028 Stratview Research has published a new report titled “Digital Pathology Market” which is segmented By Product (Software, Device [Scanners, Slide Management System], Storage, System), By Application (Drug Discovery & Development, Academic research, Disease Diagnosis, Cancer Cell Detection, Others), By End Use (Hospitals, Biotech & pharma companies, Diagnostic Labs, Academic & research institutes) and Region (North America, Europe, Asia-Pacific, and Rest of the World). As per the study, the market is expected to grow from USD 831.45 million in 2021 to USD 1816.21 million by 2028 at a CAGR of over 11.8% during the forecast period of 2022-2028. Read more: https://www.stratviewresearch.com/1566/digital-pathology-market.html Digital pathology is referred to as an image-based information setting that is enabled by computer technology which allows the management of information generated via a digital slide. Digitalization of pathology has further led to the automation of tests during disease diagnosis among other applications. A single digital device can perform tests that were previously carried out using five instruments by pathologists. These solutions offer analysis & scrutiny of images on a computer, online storage of digital slides, and high-resolution sample scanning, which helps pathologists to cross-examine slides without physical evidence. Report Highlights This report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can affect the market dynamics of the industry. It provides a thorough analysis of the market segments which include products, applications, and competitor analysis. The market is bifurcated into various segments. Below given is the segment-wise analysis - Product Trends The Device Segment witnessed the highest market share of more than 50% in 2021 and is projected to register a healthy CAGR during the assessment period. The market is segmented into software, device, storage, and system. This is mainly ascribed to the rise in academic research activities and improved resolution of slide management systems and scanners, thereby bolstering segment growth. Digital Pathology is estimated to witness lucrative growth over the forecast period because of the improvements in magnification and slide scanning at the Z-axis, which is offered by whole slide imaging. In addition, its usage rates are expected to be increased as a result of intuitive user interfaces and high bandwidth connectivity. Major players are constantly introducing technological developments for digital pathology scanners. Application Trends The Academic Research Application Segment accounted for the largest market share of more than 45.0% in 2021 and is projected to expand further at a steady CAGR from 2022 to 2028. The market is segmented into Drug Discovery & Development, Academic research, Disease Diagnosis, Cancer Cell Detection, and Others. Digital pathology is gaining popularity in various research studies, which is driving up the segment's share. In the future, several cancer therapies are estimated to be introduced, which will further boost the academic research segment. Hospitals, diagnostic labs, biotech and pharmaceutical companies, and academic and research institutes are the main sectors of this market. End-Use Trends The Hospital's Segment accounted for the largest revenue share of more than 35% in 2021 owing to the high adoption of digital scanning techniques in hospitals for faster diagnosis and better patient compliance. The market is segmented into hospitals, diagnostic labs, biotech, and pharma companies, and academic and research institutes based on end-use. In August 2020, Mackenzie Health and Philips teamed up to create one of Canada's first digital pathology platforms to assist patients in receiving faster and more effective care. Philips' IntelliSite pathology platform will help improve laboratory efficiency, increase access to specialists, and speed up diagnoses. Collaborations are expected to fuel segment growth in the near future. On the other hand, the diagnostic lab segment is anticipated to experience the fastest CAGR from 2022 to 2028. The biotechnology & pharmaceutical companies segment is anticipated to have steady demand over the period. According to the study, digital pathology will be used more frequently in drug development, oncology clinical trials, and preclinical GLP pathology over the next decade as a result of cancer and the demand for improved treatment options. Cancer is a significant factor in driving up demand for this segment. Which Region is expected to remain the largest market? The North American market accounted for the largest market share of over 40% in 2021 and is likely to grow at a robust CAGR during the review period. This can be attributed to supportive government initiatives about the development of technologically advanced systems, continual deployment of R&D investments, growing adoption of digital imaging, and the presence of major players boosting the industry growth in the region. The regional market is expected to grow at a healthy CAGR during the forecast period, thanks to the growing adoption of digital pathology for disease diagnosis and improved reimbursement policies in the U.S. However, Asia Pacific is expected to grow steadily. The increase in growth can be attributed to the rising penetration of digital imaging in emerging economies, the medical field's investments, and the availability of untapped markets in the Asia Pacific. The healthcare sector in the Asia Pacific has been highly influential due to the increased rate of cancer, which impacts a large population. Who are the Key Players in the Market? This report provides market intelligence in the most comprehensive way. It also provides critical insights into the key players active in the market, which will enable strategic decision-making for the existing market players as well as those willing to enter the market. The following are the key players acting in the Digital Pathology Market: • Danaher (The U.S.) • Hamamatsu Photonics, Inc (Japan) • Koninklijke Philips N.V. (Netherlands) • Olympus Corporation (Japan) • F. Hoffmann-La Roche Ltd (Switzerland) • Mikroscan Technologies (The U.S.) • Inspirata, Inc (The U.S.) • Visiopharm A/S (Denmark) • Huron Digital Pathology (Canada) • 3DHISTECH Ltd. (Hungary) Key questions answered by the report: • What is the projected CAGR for revenue from the Digital Pathology Market during the forecast period? • What would the market be valued at by 2028? • What is a major driving factor for the growth of the market? • Which region accounted for the largest revenue share in the Digital Pathology Market? • Which are the major market players? Custom Research: Stratview Research delivers custom research services across sectors. In case of any custom research requirements, please send your inquiry to sales@stratviewresearch.com. Or connect with our experts at +1-313-307-4176. About Us Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with insightful market data to aid strategic decision-making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.